Literature DB >> 22581448

Targeting antiapoptotic A1/Bfl-1 by in vivo RNAi reveals multiple roles in leukocyte development in mice.

Eleonora Ottina1, Francesca Grespi, Denise Tischner, Claudia Soratroi, Stephan Geley, Andreas Ploner, Holger M Reichardt, Andreas Villunger, Marco J Herold.   

Abstract

Gene-targeting studies in mice have identified the essential roles of most prosurvival Bcl-2 family members in normal physiology and under conditions of stress. The function of one member, Bcl2a1/Bfl-1/A1, is only poorly understood because of quadruplication of its gene locus in mice, hindering conventional knockout studies. To overcome this problem, we generated mouse models allowing traceable constitutive or reversible ablation of A1 in the hematopoietic system by RNA interference. Knockdown of A1 impaired early stages of T-cell differentiation, B-cell homeostasis, and sensitized transitional as well as follicular B cells to apoptosis induced by ligation of the B-cell receptor. As a consequence, B-cell proliferation in response to mitogens was severely impaired, whereas that of T cells appeared unaffected. Furthermore, depending on the extent of A1 knockdown, granulocytes showed increased spontaneous death in culture or failed to accumulate in significant numbers in vivo. These models highlight the critical role of A1 in leukocyte development and homeostasis, constituting valuable tools for investigating presumed roles of this Bcl-2 family member in immunity, tumorigenesis, and drug resistance.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22581448      PMCID: PMC3418769          DOI: 10.1182/blood-2011-12-399089

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  37 in total

1.  Downregulation of Bfl-1 protein expression sensitizes malignant B cells to apoptosis.

Authors:  G Brien; M-C Trescol-Biemont; N Bonnefoy-Bérard
Journal:  Oncogene       Date:  2007-03-12       Impact factor: 9.867

2.  The stability and anti-apoptotic function of A1 are controlled by its C terminus.

Authors:  Marco J Herold; Jonas Zeitz; Christiane Pelzer; Christa Kraus; Andrea Peters; Gisela Wohlleben; Ingolf Berberich
Journal:  J Biol Chem       Date:  2006-03-21       Impact factor: 5.157

3.  Selective roles for antiapoptotic MCL-1 during granulocyte development and macrophage effector function.

Authors:  Desiree A Steimer; Kelli Boyd; Osamu Takeuchi; Jill K Fisher; Gerard P Zambetti; Joseph T Opferman
Journal:  Blood       Date:  2008-12-08       Impact factor: 22.113

4.  Long-lived B cells are distinguished by elevated expression of A1.

Authors:  M M Tomayko; M P Cancro
Journal:  J Immunol       Date:  1998-01-01       Impact factor: 5.422

5.  Essential role for the BH3-only protein Bim but redundant roles for Bax, Bcl-2, and Bcl-w in the control of granulocyte survival.

Authors:  Andreas Villunger; Clare Scott; Philippe Bouillet; Andreas Strasser
Journal:  Blood       Date:  2002-11-14       Impact factor: 22.113

6.  Defective ubiquitin-mediated degradation of antiapoptotic Bfl-1 predisposes to lymphoma.

Authors:  Gaofeng Fan; Matthew J Simmons; Sheng Ge; Jui Dutta-Simmons; Jérôme Kucharczak; Yacov Ron; David Weissmann; Chiann-Chyi Chen; Chandreyee Mukherjee; Eileen White; Céline Gélinas
Journal:  Blood       Date:  2010-02-25       Impact factor: 22.113

7.  High expression of bfl-1 contributes to the apoptosis resistant phenotype in B-cell chronic lymphocytic leukemia.

Authors:  Alejo A Morales; Anna Olsson; Fredrik Celsing; Anders Osterborg; Mikael Jondal; Lyda M Osorio
Journal:  Int J Cancer       Date:  2005-02-20       Impact factor: 7.396

8.  Perturbation of B-cell development in mice overexpressing the Bcl-2 homolog A1.

Authors:  Peter I Chuang; Samantha Morefield; Chien-Ying Liu; Stephen Chen; John M Harlan; Dennis M Willerford
Journal:  Blood       Date:  2002-05-01       Impact factor: 22.113

9.  Tissue-specific and reversible RNA interference in transgenic mice.

Authors:  Ross A Dickins; Katherine McJunkin; Eva Hernando; Prem K Premsrirut; Valery Krizhanovsky; Darren J Burgess; Sang Yong Kim; Carlos Cordon-Cardo; Lars Zender; Gregory J Hannon; Scott W Lowe
Journal:  Nat Genet       Date:  2007-06-17       Impact factor: 38.330

Review 10.  A1/Bfl-1 in leukocyte development and cell death.

Authors:  Eleonora Ottina; Denise Tischner; Marco J Herold; Andreas Villunger
Journal:  Exp Cell Res       Date:  2012-02-04       Impact factor: 3.905

View more
  33 in total

Review 1.  Attacking cancer's Achilles heel: antagonism of anti-apoptotic BCL-2 family members.

Authors:  Joseph T Opferman
Journal:  FEBS J       Date:  2015-09-15       Impact factor: 5.542

2.  Characterisation of mice lacking all functional isoforms of the pro-survival BCL-2 family member A1 reveals minor defects in the haematopoietic compartment.

Authors:  Robyn L Schenk; Selma Tuzlak; Emma M Carrington; Yifan Zhan; Susanne Heinzel; Charis E Teh; Daniel H Gray; Lin Tai; Andrew M Lew; Andreas Villunger; Andreas Strasser; Marco J Herold
Journal:  Cell Death Differ       Date:  2017-01-13       Impact factor: 15.828

3.  The BCL-2 pro-survival protein A1 is dispensable for T cell homeostasis on viral infection.

Authors:  Selma Tuzlak; Robyn L Schenk; Ajithkumar Vasanthakumar; Simon P Preston; Manuel D Haschka; Dimitra Zotos; Axel Kallies; Andreas Strasser; Andreas Villunger; Marco J Herold
Journal:  Cell Death Differ       Date:  2017-01-13       Impact factor: 15.828

Review 4.  Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy.

Authors:  Peter E Czabotar; Guillaume Lessene; Andreas Strasser; Jerry M Adams
Journal:  Nat Rev Mol Cell Biol       Date:  2014-01       Impact factor: 94.444

5.  Guarding effector T-cell survival: all for one, Mcl-1 for all?

Authors:  E Ottina; M Pellegrini; A Villunger
Journal:  Cell Death Differ       Date:  2013-08       Impact factor: 15.828

Review 6.  Dying to protect: cell death and the control of T-cell homeostasis.

Authors:  Kun-Po Li; Sharmila Shanmuganad; Kaitlin Carroll; Jonathan D Katz; Michael B Jordan; David A Hildeman
Journal:  Immunol Rev       Date:  2017-05       Impact factor: 12.988

Review 7.  Delving deeper: MCL-1's contributions to normal and cancer biology.

Authors:  Rhonda M Perciavalle; Joseph T Opferman
Journal:  Trends Cell Biol       Date:  2012-09-28       Impact factor: 20.808

Review 8.  Lessons from gain- and loss-of-function models of pro-survival Bcl2 family proteins: implications for targeted therapy.

Authors:  Maja Sochalska; Selma Tuzlak; Alexander Egle; Andreas Villunger
Journal:  FEBS J       Date:  2015-01-23       Impact factor: 5.542

9.  Myeloid-derived suppressor activity is mediated by monocytic lineages maintained by continuous inhibition of extrinsic and intrinsic death pathways.

Authors:  Jessica M Haverkamp; Amber M Smith; Ricardo Weinlich; Christopher P Dillon; Joseph E Qualls; Geoffrey Neale; Brian Koss; Young Kim; Vincenzo Bronte; Marco J Herold; Douglas R Green; Joseph T Opferman; Peter J Murray
Journal:  Immunity       Date:  2014-12-11       Impact factor: 31.745

10.  SYK inhibition modulates distinct PI3K/AKT- dependent survival pathways and cholesterol biosynthesis in diffuse large B cell lymphomas.

Authors:  Linfeng Chen; Stefano Monti; Przemyslaw Juszczynski; Jing Ouyang; Bjoern Chapuy; Donna Neuberg; John G Doench; Agata M Bogusz; Thomas M Habermann; Ahmet Dogan; Thomas E Witzig; Jeffery L Kutok; Scott J Rodig; Todd Golub; Margaret A Shipp
Journal:  Cancer Cell       Date:  2013-06-10       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.